Articles with "18f fdopa" as a keyword



Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype

Sign Up to like & get
recommendations!
Published in 2017 at "European Journal of Nuclear Medicine and Molecular Imaging"

DOI: 10.1007/s00259-017-3833-y

Abstract: Introduction18F-FDOPA illustrates the properties of uptake and storage of catecholamines in pheochromocytomas (PHEOs). Until now, the relationship between 18F-FDOPA quantitative parameters and a PHEO secretory profile has not been specifically evaluated.Materials and methodsFifty-six patients (56%… read more here.

Keywords: pet; 18f fdopa; biochemical phenotype; correlation ... See more keywords

Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas

Sign Up to like & get
recommendations!
Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"

DOI: 10.1007/s00259-019-04509-y

Abstract: 18F-FDopa PET imaging of gliomas is routinely interpreted with standardized uptake value (SUV)-derived indices. This study aimed to determine the added value of dynamic 18F-FDopa PET parameters for predicting the molecular features of newly diagnosed… read more here.

Keywords: 18f fdopa; gliomas; idh; fdopa pet ... See more keywords

Update on the Role of [18F]FDOPA PET/CT.

Sign Up to like & get
recommendations!
Published in 2024 at "Seminars in nuclear medicine"

DOI: 10.1053/j.semnuclmed.2024.09.004

Abstract: [18F]-dihydroxyphenylalanine ([18F]FDOPA) is a radiopharmaceutical used in a broad spectrum of diseases, including neuroendocrine tumors (NETs), congenital hyperinsulinism, parkinsonian syndromes and neuro-oncology. Genetic analysis and disease specific biomarkers may guide the optimum selection of patients… read more here.

Keywords: oncology; fdopa pet; 18f fdopa; congenital hyperinsulinism ... See more keywords

BIOM-37. EXPLORING L-TYPE AMINO ACID TRANSPORTER 1 (LAT1) AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)

Sign Up to like & get
recommendations!
Published in 2024 at "Neuro-Oncology"

DOI: 10.1093/neuonc/noae165.0110

Abstract: Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft tissue sarcomas that frequently arise from benign plexiform neurofibromas (PN). Approximately half of MPNST are associated with Neurofibromatosis type 1 (NF1). Despite partial elucidation of the… read more here.

Keywords: 18f fdopa; type; mpnst cells; lat1 ... See more keywords

IMG-42. Contribution of 18F-FDOPA PET imaging for target volume delineation in stereotactic radiosurgery treatment planning for brain metastasis: a pilot study

Sign Up to like & get
recommendations!
Published in 2025 at "Neuro-Oncology"

DOI: 10.1093/neuonc/noaf201.1121

Abstract: Positron emission tomography (PET) has become an important imaging test in the diagnosis of brain tumors. Amino acid and amino acid analog PET tracers, including 18F-FET, 11C-MET and 18F-FDOPA, are particularly attractive for imaging of… read more here.

Keywords: 18f fdopa; brain; fdopa pet; pet ... See more keywords

Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical Nuclear Medicine"

DOI: 10.1097/rlu.0000000000001496

Abstract: Purpose The use of 18Fluorine-labeled dihydroxy-phenyl-alanine (18F-FDOPA) PET/CT in patients with hypoglycemia suspected to be caused by pancreatic disease can be helpful to localize the source of excess insulin production. In this setting, carbidopa pretreatment… read more here.

Keywords: carbidopa pretreatment; gastric bypass; 18f fdopa; without carbidopa ... See more keywords

18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma.

Sign Up to like & get
recommendations!
Published in 2020 at "Clinical Nuclear Medicine"

DOI: 10.1097/rlu.0000000000002959

Abstract: Amino acid PET, including F-FDOPA, is recommended for initial characterization, delineation of tumor extent, and follow-up of gliomas because of its high diagnostic performances. F-FDOPA accumulates inside tumor cells via the L-type amino acid transporter… read more here.

Keywords: fdopa; findings patient; fdopa pet; 18f fdopa ... See more keywords

Orbital Metastasis: A Rare but Typical Location of Small Intestine Neuroendocrine Tumor on 18F-FDOPA PET/CT.

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical nuclear medicine"

DOI: 10.1097/rlu.0000000000004137

Abstract: ABSTRACT Orbital foci of increased uptake are sometimes visualized on 18F-FDOPA PET/CT, but the literature remains poor as to their nature. The orbit is indeed a rare site of metastatic involvement. Given this low probability… read more here.

Keywords: small intestine; intestine neuroendocrine; neuroendocrine tumor; 18f fdopa ... See more keywords

18F-FDOPA PET/CT of Paraganglioma in the Spermatic Cord.

Sign Up to like & get
recommendations!
Published in 2023 at "Clinical nuclear medicine"

DOI: 10.1097/rlu.0000000000004616

Abstract: ABSTRACT A 53-year-old man with chronic kidney failure was referred to perform an 18F-FDOPA PET/CT to characterize a mass located on the right spermatic cord. Previously, the pathological analysis of CT-guided biopsies suggested paraganglioma or… read more here.

Keywords: spermatic cord; 18f fdopa; paraganglioma; fdopa pet ... See more keywords

Comparison of 18F-FDOPA and 18F-MFBG PET/CT Images of Metastatic Pheochromocytoma.

Sign Up to like & get
recommendations!
Published in 2023 at "Clinical nuclear medicine"

DOI: 10.1097/rlu.0000000000004664

Abstract: ABSTRACT A 30-year-old man with pheochromocytoma was hospitalized for hemoptysis without inducement. CT revealed a mass in the left lung, and biopsy pathology under the bronchoscope suggested that it was a pheochromocytoma metastasis. To further… read more here.

Keywords: 18f mfbg; fdopa 18f; 18f fdopa; mfbg pet ... See more keywords

Optimization of [18F]-FDOPA Brain PET Acquisition Times for Assessment of Parkinsonism in the Clinical Setting

Sign Up to like & get
recommendations!
Published in 2024 at "American Journal of Neuroradiology"

DOI: 10.3174/ajnr.a8207

Abstract: BACKGROUND AND PURPOSE: Fluorine 18-fluoro-L-dopa ([18F]-FDOPA) was approved by the FDA in 2019 and reimbursed by the Centers for Medicare & Medicaid Services in 2022 for use with PET to visualize dopaminergic nerve terminals in… read more here.

Keywords: acquisition; acquisition times; 18f fdopa; image quality ... See more keywords